Cronos Group Inc. (CRON)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.40
-1.02%
Mkt Cap $1.23B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$3.15
Range $2.30 – $4.50
Implied Upside
-7.4%
Consensus $3.15 vs current $3.40